1. Home
  2. AFMD vs MHUA Comparison

AFMD vs MHUA Comparison

Compare AFMD & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFMD
  • MHUA
  • Stock Information
  • Founded
  • AFMD 2000
  • MHUA 1990
  • Country
  • AFMD Germany
  • MHUA China
  • Employees
  • AFMD N/A
  • MHUA N/A
  • Industry
  • AFMD Biotechnology: Pharmaceutical Preparations
  • MHUA Medical Specialities
  • Sector
  • AFMD Health Care
  • MHUA Health Care
  • Exchange
  • AFMD Nasdaq
  • MHUA Nasdaq
  • Market Cap
  • AFMD 17.5M
  • MHUA 15.6M
  • IPO Year
  • AFMD 2014
  • MHUA 2022
  • Fundamental
  • Price
  • AFMD $1.15
  • MHUA $0.32
  • Analyst Decision
  • AFMD Strong Buy
  • MHUA
  • Analyst Count
  • AFMD 5
  • MHUA 0
  • Target Price
  • AFMD $13.50
  • MHUA N/A
  • AVG Volume (30 Days)
  • AFMD 363.4K
  • MHUA 897.2K
  • Earning Date
  • AFMD 11-14-2024
  • MHUA 09-20-2024
  • Dividend Yield
  • AFMD N/A
  • MHUA N/A
  • EPS Growth
  • AFMD N/A
  • MHUA 29.93
  • EPS
  • AFMD N/A
  • MHUA 0.37
  • Revenue
  • AFMD $6,287,085.00
  • MHUA $94,252,537.00
  • Revenue This Year
  • AFMD N/A
  • MHUA N/A
  • Revenue Next Year
  • AFMD $212.48
  • MHUA N/A
  • P/E Ratio
  • AFMD N/A
  • MHUA $0.89
  • Revenue Growth
  • AFMD N/A
  • MHUA N/A
  • 52 Week Low
  • AFMD $1.03
  • MHUA $0.25
  • 52 Week High
  • AFMD $8.95
  • MHUA $1.47
  • Technical
  • Relative Strength Index (RSI)
  • AFMD 28.57
  • MHUA 37.70
  • Support Level
  • AFMD $1.03
  • MHUA $0.30
  • Resistance Level
  • AFMD $1.41
  • MHUA $0.35
  • Average True Range (ATR)
  • AFMD 0.11
  • MHUA 0.03
  • MACD
  • AFMD 0.05
  • MHUA 0.01
  • Stochastic Oscillator
  • AFMD 23.53
  • MHUA 36.35

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

About MHUA Meihua International Medical Technologies Co. Ltd.

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.

Share on Social Networks: